{"schema":"hottub-news/story/v1","story":"st_fiim3mhswkf7bxhnuhsq","title":"ITM and Lumara Bio Announce Real-World Re-treatment Data and Dosimetry Results from COMPETE for ¹⁷⁷Luedotreotide (ITM-11) in GEP-NETs at ASTRO 2026","title_en":null,"outlets":2,"brief":null,"page":"https://hottub.news/stories/itm-and-lumara-bio-announce-real-world-re-treatment-data-and-dosimetry-fiim3mhswk","count":2,"items":[{"id":"n_6kolp6ewrzv4inpwkyva","seq":303056,"kind":"article","title":"ITM and Lumara Bio Announce Real-World Re-treatment Data and Dosimetry Results from COMPETE for ¹⁷⁷Luedotreotide (ITM-11) in GEP-NETs at ASTRO 2026","url":"https://www.manilatimes.net/2026/09/28/tmt-newswire/globenewswire/itm-and-lumara-bio-announce-real-world-re-treatment-data-and-dosimetry-results-from-compete-for-luedotreotide-itm-11-in-gep-nets-at-astro-2026/2433718","published":"2026-09-27T20:02:00Z","seen":"2026-09-27T21:21:36Z","lang":"en","source":{"id":"manilatimes.net","name":"manilatimes.net","domain":"manilatimes.net","outlet":{"wikidata":"Q1573100","name":"The Manila Times","type":"magazine","country":"PH","designations":["organization","periodical"]}},"via":"gdelt-gkg-english","topics":["economy","science","education","health"],"story":"st_fiim3mhswkf7bxhnuhsq","category":"science-technology","category_p":0.5400000214576721,"sentiment":"neutral","tone":0.23000000417232513,"political":0.07000000029802322},{"id":"n_fiim3mhswkf7bxhnuhsq","seq":296187,"kind":"press_release","title":"ITM and Lumara Bio Announce Real-World Re-treatment Data and Dosimetry Results from COMPETE for ¹⁷⁷Luedotreotide (ITM-11) in GEP-NETs at ASTRO 2026","url":"https://www.globenewswire.com/news-release/2026/09/27/3369463/0/en/itm-and-lumara-bio-announce-real-world-re-treatment-data-and-dosimetry-results-from-compete-for-luedotreotide-itm-11-in-gep-nets-at-astro-2026.html","summary":"Boston, Massachusetts, September 27 , 2026 — ITM Isotope Technologies Munich SE (ITM) , a leading radiopharmaceutical biotech company, and Lumara Bio , a dedicated oncology therapeutics division of ITM, today announced encouraging new data of non-carrier-added (n.c.a.) 177 Lu-edotreotide in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The findings were presented in two posters at the American Society for Radiation Oncology (ASTRO) 2026 Annual…","published":"2026-09-27T20:00:00Z","seen":"2026-09-27T20:05:55Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business","research","events","corporate"],"entities":[{"id":"Q1576899","name":"Universiti Teknologi MARA","type":"org"}],"story":"st_fiim3mhswkf7bxhnuhsq","category":"science-technology","category_p":0.5400000214576721,"sentiment":"neutral","tone":0.33000001311302185,"political":0.07000000029802322}]}